Call for Abstracts, Surgical Films, & International Session Submissions

SGO encourages all medical professionals who are part of the women's cancer care team to submit original research for peer-review by the 2018 Annual Meeting Program Committee.

Abstract, surgical films, and international session submissions are selected on the basis of scientific merit and are allocated to Scientific Plenary, Education Symposium, Featured Poster or Poster Presentations, or Surgical Film Session through a blinded peer review process. The Program Committee reserves the right to select the most appropriate forum for Presentation.

RESEARCH CONSIDERATIONS:

Authors are encouraged to submit abstracts and surgical films pertaining to the nine key concepts below. Key Concepts should be used as a guide for the peer review process of all submitted abstracts, films, and international session submissions, not as a restriction of topics allowed for submission. Accordingly, please note which key concept is most accurate for the peer reviewer of your abstract. All other topics concerning women's cancer will be accepted for research consideration as well.

Key Concept 1: Immunotherapy
Science and Clinical Trials: Basic, translational and clinical studies investigation of tumor immunology and immune environment, immunotherapy based treatment approaches, and novel targets.

Key Concept 2: Surgical Innovation and Enhanced Recovery
Improving surgical quality, outcomes, and recovery.

Key Concept 3: Healthcare Policy and Advocacy
Initiatives and studies that address policy and advocacy positions aimed at improving access and receipt of care for gynecologic oncology patients.

Key Concept 4: International Gynecologic Cancer Care and Delivery
Comparative delivery of International Gynecologic Oncology Cancer and looking at the differentiating standards from International to US of care and cost control.

Key Concept 5: Precision and Personalized Medicine
Tumor vulnerabilities, targeted therapies, mechanisms of resistance, and biomarkers for response.

Key Concept 6: Healthcare Outcomes/Population Health Management
Cost effectiveness, quality outcomes and quality measures.

Key Concept 7: Health Disparities in Gynecologic Oncology
Translational and clinical studies, including health services research, describing disparities in gynecologic cancer treatment receipt and outcome.

Key Concept 8: Rare Tumors and GTD
Emerging pathology, treatment and novel therapies in development.

Key Concept 9: Clinical Trials (in progress or completed)
From personalized medicine to practice-changing studies in ovarian, cervical and endometrial cancers.

Key Concept 10: Healthcare Provider Wellness
Work-life balance, understanding sources of stress and coping strategies.

Key Concept 11: Palliative Care and Patient Reported Outcomes
Pain and side effect management, survivorship, sexual function, and novel approaches to survival and patient experience.

Key Concept 12: Education - Surgical and Non-surgical
Advancement of education and training through novel strategies, simulation, and electronic media.

*Note: Key Concepts for international session submissions are listed below:
Link to International Session Submissions details and submission

Other Women's Cancer Topics to Consider:

  • Breast Cancer
  • Cervical Cancer
  • Chemotherapy
  • Clinical Practice Issues
  • Clinical Trials - Phase I
  • Clinical Trials - Ovary/FP/PPC/Breast, Phase II/III
  • Clinical Trials - Cervix Phase II/III
  • Clinical Trials - Endometrial/Sarcoma, Phase II/III
  • Endometrial Cancer
  • Public Health/Epidemiology
  • Hereditary Cancers & The Role Of Genetics
  • Ovarian/FP/PPC
  • Surgical Techniques/ Robotics/Minimally Invasive Surgery
  • Supportive Care
  • Quality of Life
  • GTD/Vulvar & Vaginal Cancers/Rare Tumors/Sarcomas
  • Surgical Films
  • Translational Research/Basic Science

Objectives, Methods, Results, and Conclusions must be clearly identified within the submission.

Individuals with abstracts selected for presentation will be asked to postpone publication of their manuscript in any journal until the conclusion of the Annual Meeting. Abstracts selected for Scientific Plenary, Education Forum, Featured Poster or Poster Presentations will be published in Gynecologic Oncology. For those authors wishing to submit manuscripts for publication in Gynecologic Oncology, its editors will make every effort to ensure that accepted papers are promptly published after the Annual Meeting.

There is a 2,000 character count limit for all submissions. This does not include your Title or Author String, allotted tables or graphs or spaces.

To start a new abstract, film, or international session submissions, select the appropriate submission type below. If you have started an abstract submission and have an ID and password, please login at the upper right-hand side of this page.

BEGIN A SUBMISSION BY SELECTING THE TYPE BELOW:

  1. International Session Submissions

    Start for New Submissions: Wednesday, July 19, 2017
    Submission Deadline: Wednesday, November 15, 2017, at 11:59pm Central Time

    International session submissions will be selected on the basis of scientific merit and relevance to the new course, International Gynecologic Oncology - An Interactive Session, for presentation as a poster to be followed by lectures pertaining to the topics of selected international session submissions. All international session submissions will be reviewed through a double blinded peer review process.

    This 2018 SGO International Program will emphasize international gynecologic cancer epidemiology. Our goals are to identify geographic variations in the worldwide gynecologic cancer incidence with a particular emphasis on the burden of gynecologic cancers in low and middle income countries, the challenges of public health reporting and examples of successful models for the development and implementation of reliable and accurate cancer registries.

    Key Concepts:

    Epidemiology

    Regional demographics and trends

    Treatment in developing countries

    Challenges in public health and data ascertainment

    Screening challenges

    Breast cancer

    Each international session submissions must clearly identify the following:

    Background/Objectives: an introductory sentence indicating the purpose of the study

    Disease/Procedure/Practice Issue: a brief description of pertinent experimental procedures, including statistical evaluation where appropriate

    Outcomes: a summary of the data

    Conclusions: a statement of the conclusions

    Please note: The character count limit of 2,000 does not include your international session submissions title, author string, allotted tables or graphs or spaces.

    Notification of abstract status will be delivered by early December.

  1. Abstract Submission

    Start for New Submissions: Wednesday, July 19, 2017
    Submission Deadline: Monday, September 18, 2017, at 11:59pm Central Time

    Each Abstract Submission must clearly identify the following:

    Objectives: an introductory sentence indicating the purpose of the study

    Methods: a brief description of pertinent experimental procedures, including statistical evaluation where appropriate

    Results: a summary of the NEW, UNPUBLISHED DATA

    Conclusions: a statement of the conclusions

    Please note: The character count limit of 2,000 does not include your abstract title, author string, allotted tables or graphs or spaces.

    Notification of abstract status will be delivered by mid-November, 2017.

     
  1. Surgical Film Submission

    Start for New Submissions: Wednesday, July 19, 2017
    Submission Deadline: Monday, September 18, 2017, at 11:59pm Central Time

    Peer-reviewed surgical films selected to the 2018 Annual Meeting program will be featured in Scientific Plenary, Education Symposia or Surgical Forum sessions.

    Surgical Film submissions will be evaluated based on educational content and audio/visual quality. All films must also meet the following requirements:

    1. Films must be uploaded to the submission site for consideration.
    2. Films cannot exceed 10 minutes in duration.
    3. Films must include sound.
    4. Films must be at regular speed.
    5. Films must be submitted in .AVI, .MOV, or .MP4 formats.
    6. Films may not be biased to one product.

    The maximum file size available for upload is 200 MB; larger files will not upload completely and therefore, will not be considered for presentation. Please contact education@sgo.org if your file size exceeds 200MB.

    If your surgical film is accepted for presentation at the Annual Meeting, you will be required to attend the session to orally introduce your film. Submitters may access their submissions by logging in to their online ready room any time until the submission deadline.

    Notification of abstract status will be delivered by mid-November, 2017.

     

GENERAL GUIDELINES:

  1. General Submission Regulations

    1. Membership in SGO is not required for any presenting author or co-author noted on the Abstract or Surgical Film submission.
    2. Author disclosure for the presenting author must be declared at the time of abstract submission. If the presenting author is employed by a company as defined by the CMSS Code for Interactions with Companies (http://www.cmss.org/codeforinteractions.aspx), an alternate presenter who does not have a relevant employment relationship must be named if the abstract is accepted.
    3. Submission of an Abstract constitutes a commitment by the author(s) to present it if accepted.
    4. Please write your text in proper English (American or British usage is accepted, but not a mixture of these). Use decimal points (not commas). Please carefully check your spelling.
    5. An Abstract or Surgical Film must have a title that indicates the nature of the investigation. Use sentence case and capitalize the first word in the title only.
      Example: The current clinical use of HPV genotyping
    6. Do not use abbreviations in the title of the abstract, with the exception of DNA, RNA, and HPV.
      Standard abbreviations may be used without definition in the text. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
    7. A maximum of 25 authors may be listed for a given abstract.
    8. Author names should be written in full. Please only include the primary degree for each author (for example, MD, PhD).
      If an author's name appears on more than one abstract, it must be identical on each abstract. You should not include authors' names in the body of the abstract.
    9. Within the title and text of the abstract, omit any reference to your institution to ensure proper-blinded review.
    10. Use generic drug names and International Systems Units. Trade names should not be used.
  2. Onsite Regulations

    Unauthorized recordings of sessions by means of audio tapes, video, or still photography requiring flash devices, special lighting, or bulky equipment are prohibited. The SGO reserves the right to all video and/or audio recordings of presentations at The Annual Meeting on Women's Cancer.

    Expenses associated with the submission and presentation of an abstract for a Plenary, Education Symposium, Surgical Forum, Featured Poster or Poster are the responsibility of the presenter.

    SGO Reserves the right to reject abstracts if the aforementioned rules are not followed.

  3. Technical Support

    If you require technical assistance during the submission process, feel free to contact Technical Support
    • Via Email
    • Via Telephone 401-334-9902 between the hours of 8:30 AM and 6:00 PM Monday through Friday, US Eastern Standard Time (GMT -05:00). At the prompt, enter support code 1434.